7 UGC de Reumatología, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain Correspondence to Dr Jose L Pablos, Servicio de Reumatología, ...
Objective To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other ...
1 Northern Clinical School, Institute of Bone and Joint Research, University of Sydney, St Leonards, New South Wales, Australia 2 Department of Rheumatology, Royal North Shore Hospital, St Leonards, ...
1 University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, ...
Correspondence to Dr Annette H M van der Helm-van Mil, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden 2300 RC, The Netherlands; AvdHelm{at}lumc.nl Background ...
1 Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK 2 Department of Rheumatology, Medical School, Newcastle University, Newcastle upon Tyne, UK 3 Department ...
Dr G Peat, Primary Care Sciences Research Centre, School of Postgraduate Medicine, Keele University, The Medical Institute, Hartshill Road, Stoke-on-Trent ST7 4NY, UKg.m.peat{at}hfac.keele.ac.uk ...
UPRES EA 1124- Ecole de Santé Publique, Faculté de Médecine, Nancy, France Professor F Guillemin, Ecole de Santé Publique, Faculté de Médecine, 9 Avenue de la Forêt de Haye, BP 184, F 54500 Vandoeuvre ...
Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain, somatic and mental fatigue ...
Objectives To examine the safety and efficacy of rontalizumab, a humanised IgG1 anti-interferon α (anti-IFN-α) monoclonal antibody, in patients with moderate-to-severe systemic lupus erythematosus ...
Objective Epidemiological studies of primary Sjögren's syndrome (pSS) are crucial for describing the burden to society and the public medical system and for shedding light on aetiology. Previous ...
Objective To evaluate ustekinumab efficacy and safety in psoriatic arthritis (PsA) patients with peripheral arthritis and physician-reported spondylitis (termed the ‘spondylitis subset’). Methods ...